Abstract
Background: Tribulus terrestris, unlike Tribulus macropterus and Tribulus arabicus, is a well-studied plant species and well known for its medicinal properties. It has been used as a medicine to treat sexual dysfunction and to relieve cardiac pain. It also has other properties such as antihypertensive, anti-microbial, anticancer and antihelmintic. Unfortunately, other Tribulus species such as T. macropterus and T. arabicus (common in the UAE), were not thoroughly investigated for such medicinal properties.
Methods: In this trial, Tribulus terrestris (TT), Tribulus macropterus (TM) and Tribulus arabicus (TA) were tested for their antixodiant properties using DPPH, ABTS, FRAP and β-Carotene assays. Results: TM and TA showed similar or slightly greater antioxidant properties than TT. Similar DPPH scavenging activities (presented as inhibition percent) were observed for both TM (42.7%) and TA (43.8%), and slightly higher than TT (39.9%) at the maximum concentrations (i.e., 1000 ug/ml). For β-Carotene, TT showed absorbance of 0.28 (control) and 0.35 (at 1000 ug/ml). TM and TA had averages of 0.38 and 0.49 vs 0.190 and 0.23 (control and at 1000 ug/ml, respectively) at 470 nm. Conclusion: The results reported here showed similar antioxidant potentials of T. macropterus and T. arabicus when compared to T. terrestris, which place these two Tribulus species at similar levels of antioxidant and medicinal properties as T. terrestris. A subsequent investigation on the potentials of T. macropterus and T. arabicus against sexual dysfunctions in rats is planned. The long-term aim would be to treat sexual dysfunctions in humans using T. macropterus and T. arabicus as an alternative to T. terrestris.Keywords: Plant extracts, sexual dysfunctions, Tribulus, UAE.
Graphical Abstract
Current Bioactive Compounds
Title:Tribulus arabicus and Tribulus macropterus are Comparable to Tribulus terrestris: An Antioxidant Assessment
Volume: 13 Issue: 1
Author(s): Taoufik Ksiksi, Abdul Rasheed Palakkott and Shaijal B.T. Ppoyil
Affiliation:
Keywords: Plant extracts, sexual dysfunctions, Tribulus, UAE.
Abstract: Background: Tribulus terrestris, unlike Tribulus macropterus and Tribulus arabicus, is a well-studied plant species and well known for its medicinal properties. It has been used as a medicine to treat sexual dysfunction and to relieve cardiac pain. It also has other properties such as antihypertensive, anti-microbial, anticancer and antihelmintic. Unfortunately, other Tribulus species such as T. macropterus and T. arabicus (common in the UAE), were not thoroughly investigated for such medicinal properties.
Methods: In this trial, Tribulus terrestris (TT), Tribulus macropterus (TM) and Tribulus arabicus (TA) were tested for their antixodiant properties using DPPH, ABTS, FRAP and β-Carotene assays. Results: TM and TA showed similar or slightly greater antioxidant properties than TT. Similar DPPH scavenging activities (presented as inhibition percent) were observed for both TM (42.7%) and TA (43.8%), and slightly higher than TT (39.9%) at the maximum concentrations (i.e., 1000 ug/ml). For β-Carotene, TT showed absorbance of 0.28 (control) and 0.35 (at 1000 ug/ml). TM and TA had averages of 0.38 and 0.49 vs 0.190 and 0.23 (control and at 1000 ug/ml, respectively) at 470 nm. Conclusion: The results reported here showed similar antioxidant potentials of T. macropterus and T. arabicus when compared to T. terrestris, which place these two Tribulus species at similar levels of antioxidant and medicinal properties as T. terrestris. A subsequent investigation on the potentials of T. macropterus and T. arabicus against sexual dysfunctions in rats is planned. The long-term aim would be to treat sexual dysfunctions in humans using T. macropterus and T. arabicus as an alternative to T. terrestris.Export Options
About this article
Cite this article as:
Ksiksi Taoufik, Palakkott Rasheed Abdul and Ppoyil B.T. Shaijal, Tribulus arabicus and Tribulus macropterus are Comparable to Tribulus terrestris: An Antioxidant Assessment, Current Bioactive Compounds 2017; 13 (1) . https://dx.doi.org/10.2174/1573407212666161014130546
DOI https://dx.doi.org/10.2174/1573407212666161014130546 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Current Cancer Therapy Reviews Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design Engineering Approaches to Develop the Next Generation of Antibodies to Respiratory Targets
Inflammation & Allergy - Drug Targets (Discontinued) Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer
Mini-Reviews in Medicinal Chemistry Azacitidine Loaded PLGA Nanoparticles and their Dual Release Mechanism
Current Nanomedicine Antineoplastic Activities, Apoptotic Mechanism of Action and Structural Properties of a Novel Silver(I) Chelate
Current Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Network-Based Strategies Can Help Mono- and Poly-pharmacology Drug Discovery: A Systems Biology View
Current Pharmaceutical Design Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Current Drug Metabolism Ciprofloxacin Stress Proteome of the Extended-Spectrum β-lactamase Producing Escherichia coli from Slaughtered Pigs
Current Proteomics Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Pharmaceutical Applications of the Benzylisoquinoline Alkaloids from Argemone mexicana L.
Current Topics in Medicinal Chemistry Exposure and Genotoxicity Assessment Methodologies - The Case of Formaldehyde Occupational Exposure
Current Analytical Chemistry Epidemiology and Prevention of Viral Infections in Patients with Hematologic Malignancies
Infectious Disorders - Drug Targets FoxO Proteins: Regulation and Molecular Targets in Liver Cancer
Current Medicinal Chemistry Gene Therapy for Wiskott-Aldrich Syndrome
Current Gene Therapy Regulatory T Cells as Targets for Immunotherapy of Autoimmunity and Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Retinal Ganglion Cell Gene Therapy and Visual System Repair
Current Gene Therapy Involvement of Mast Cells in Angiogenesis and Chronic Inflammation
Current Drug Targets - Inflammation & Allergy BCR/ABL1 Fusion Transcripts Generated from Alternative Splicing: Implications for Future Targeted Therapies in Ph+ Leukaemias
Current Molecular Medicine